Healthy men test new Drug's safety and absorption
NCT ID NCT02068690
First seen May 05, 2026 · Last updated May 16, 2026 · Updated 3 times
Summary
This early-stage study tested a new drug called BI 425809 in 83 healthy men to see if it was safe and how the body handles it. Researchers gave single rising doses and compared different forms (liquid vs. tablet) and the effect of food. The goal was to gather safety data and understand the drug's behavior, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
1346.1.1 Boehringer Ingelheim Investigational Site
Ingelheim, Germany
Conditions
Explore the condition pages connected to this study.